# US FDA approves Asahi Kasei drug for persistent herpes infections

https://mins.news/en/item/93772

- Reuters, 2026-10-09 19:45 UTC
- Health
- Original: https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-asahi-kaseis-drug-persistent-herpes-infections-2026-10-09/?link_source=ta_bluesky_link&taid=6ac9444a8f1582000191abf1

> The US FDA approved a drug from Japan's Asahi Kasei on Friday for persistent herpes simplex virus sores in certain immunocompromised patients who have not responded to available antiviral treatments.